Pharmos Corp. announced unaudited consolidated financial results for the first quarter ended March 31, 2012. For the quarter, the company reported loss from operations of $551,336 against $576,754 a year ago. Net loss was $576,305 or $0.01 per basic and diluted share against $603,127 or $0.01 per basic and diluted share a year ago.